IDO1 and esophageal squamous cell carcinoma: These results suggest that serum HMGB1 and IDO levels in ESCC patients are significantly higher than those in healthy people, and with the progression of the disease in ESCC patients, serum HMGB1 and IDO levels are gradually increasing, which may have a synergistic effect in the progression of the disease in ESCC patients.